Evidence That Mannosyl Residues Are Involved in Human Immunodeficiency Virus Type 1 (HIV-1) Pathogenesis
- 1 January 1987
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 3 (3) , 265-282
- https://doi.org/10.1089/aid.1987.3.265
Abstract
The Human Immunodeficiency Virus (HIV), the causative agent of AIDS, is thought to bind to T4+ (CD4+) target cells through the heavily glycosylated gp120 envelope glycoprotein. Plant lectins bind glycoproteins through noncovalent interaction with specific hexose residues; therefore, lectins were evaluated for their ability to inactivate HIV in vitro. The mannose-specific lectins concanavalin-A and succinyl concanavalin-A completely inactivated HIV while lentil lectin, wheat germ agglutinin, and phytohemagglutinin-P substantially inactivated HIV. BS-II, Vicia villosa (hairy vetch), and Ptilota plumosa (red marine algae) failed to alter the infectibility of HIV. Neither simple stearic hindrance, viral aggregation, nor lectin-cell interactions served to explain this phenomenon. Glycoprotein glycosylation was evaluated by differential lectin binding as well as molecular weight changes in gp120 when virus was produced in the presence of swainsonine, a glycosylation inhibitor. Lentil lectin bound gp120 better than concanavalin-A, suggesting the majority of glycosylation sites are fucosylated. The apparent molecular weight of gp120 was reduced by swainsonine, although HIV infectivity and concanavalin-A inactivation were retained. Thus, at least some N-glycosylation sites are complextype glycoproteins but regions external to the (GlcNAc)2(Man)3 "core" pentasaccharide region are not required for HIV infectivity. It appears that the site or sites involved are nonfucosylated, high mannose and/or biantennary, nonsialylated, N-glycosylated regions of gp120 or gp41. Alternatively, they may be in close approximation to such carbohydrate regions.This publication has 33 references indexed in Scilit:
- The Role of Mononuclear Phagocytes in HTLV-III/LAV InfectionScience, 1986
- Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicityNature, 1986
- Binding of HTLV-III/LAV to T4 + T Cells by a Complex of the 110K Viral Protein and the T4 MoleculeScience, 1986
- Patients at Risk for AIDS-Related Opportunistic InfectionsNew England Journal of Medicine, 1985
- The T4 Lymphocyte in AIDSNew England Journal of Medicine, 1985
- Qualitative Analysis of Immune Function in Patients with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1985
- Major Glycoprotein Antigens That Induce Antibodies in AIDS Patients Are Encoded by HTLV-IIIScience, 1985
- AIDS — An Immunologic ReevaluationNew England Journal of Medicine, 1984
- Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)Science, 1983
- RELATIONSHIPS BETWEEN THE STRUCTURE AND ACTIVITIES OF CONCANAVALIN A*Annals of the New York Academy of Sciences, 1974